Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 17.5.2016 | EN | Official Journal of the European Union | C 175/16 |

---

Order of the General Court of 16 March 2016 — Pharm-a-care Laboratories v OHIM — Pharmavite (VITAMELTS)

(Case T-713/15)[(1)](#ntr1-C_2016175EN.01001601-E0001)

((Community trade mark - Invalidity proceedings - Withdrawal of the application for a declaration of invalidity - No need to adjudicate))

(2016/C 175/18)

Language of the case: English

Parties

Applicant: Pharm-a-care Laboratories Pty. Ltd (Sydney, Australia) (represented by: I.A. De Freitas, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: E. Zaera Cuadrado, acting as Agent)

Other party to the proceedings before the Board of Appeal of OHIM: Pharmavite LLC (California, United States)

Re:

Action brought against the decision of the First Board of Appeal of OHIM of 10 September 2015 (Cases R 2649/2014-1) concerning invalidity proceedings between Pharmvite LLC and Pharm-a-care Laboratories Pty. Ltd.

Operative part of the order

|  |  |
| --- | --- |
| 1. | There is no longer any need to adjudicate in the action. |

|  |  |
| --- | --- |
| 2. | Pharm-a-care Laboratories Pty. Ltd shall bear its own costs and shall pay the costs incurred by the Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM). |

---

[Top](#document1)